Cardiac Structural Remodeling and Hemodynamic Patterns Following Transcatheter Aortic Valve Replacement
- PMID: 34877202
- PMCID: PMC8642138
- DOI: 10.7759/cureus.19224
Cardiac Structural Remodeling and Hemodynamic Patterns Following Transcatheter Aortic Valve Replacement
Abstract
Background Transcatheter aortic valve replacement (TAVR) is increasingly utilized for most patients with symptomatic severe aortic stenosis. TAVR is linked to enhanced long-term cardiac hemodynamics, reversal of left ventricle (LV) hypertrophy, and improved aortic valve gradients. We present a retrospective observational study assessing cardiac remodeling and valvular flow patterns post-TAVR. Methods Retrospective echocardiographic data were collected, evaluating cardiac function and valvular flow patterns before and after TAVR at a single institution. Data was compiled and statistically analyzed using a paired t-test evaluating variations at approximately 30 days and one-year post-TAVR. Results On echocardiogram 30 days and one-year post-TAVR, there was a reduction in LV mass index from 132 g/m² to 110 g/m² (95%CI: 98-122; p=0.01) and 118 g/m² (95%CI: 102-133; p=0.03), and a reduction in relative wall thickness from 0.54 to 0.49 (95%CI: 0.46-0.52; p=0.05) and 0.44 (95%CI: 0.38-0.49; p=0.03), respectively. Doppler velocity indices (DVI) increased from 0.24 to 0.61 (95%CI: 0.49-0.73; p<0.001) and 0.57 (95%CI: 0.48-0.65; p<0.001). Expected improvement in aortic valve velocities and gradients were observed post-TAVR. Conclusions Following TAVR, LV remodeling can be observed as early as 30 days. This is demonstrated by a reduction in LV mass index and relative wall thickness in conjugation with an anticipated improvement in valvular flow patterns and flow across the aortic valve.
Keywords: aortic stenosis; echocardiography; remodeling; tavi; tavr.
Copyright © 2021, Feghaly et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- Transcatheter versus surgical aortic-valve replacement in high-risk patients. Smith CR, Leon MB, Mack MJ, et al. N Engl J Med. 2011;364:2187–2198. - PubMed
-
- Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. Mack MJ, Leon MB, Thourani VH, et al. N Engl J Med. 2019;380:1695–1705. - PubMed
-
- 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Otto CM, Nishimura RA, Bonow RO, et al. Circul. 2021;143:0. - PubMed
-
- 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Mack MJ, Leon MB, Smith CR, et al. Lancet. 2015;385:2477–2484. - PubMed
-
- 5-year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients. Gleason TG, Reardon MJ, Popma JJ, et al. J Am Coll Cardiol. 2018;72:2687–2696. - PubMed
LinkOut - more resources
Full Text Sources